Amneal Intermediate Inc banner
A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 13.26 USD -4.67% Market Closed
Market Cap: $4.2B

Revenue Breakdown

Breakdown by Geography
Amneal Intermediate Inc

Not Available

Breakdown by Segments
Amneal Intermediate Inc

Total Revenue: 3B USD
100%
Subtotal Dosage Forms: 1.7B USD
55.5%
Oral Solid: 689.4m USD
22.8%
Subtotal Therapeutic Classes: 439.2m USD
14.5%
Distribution: 434m USD
14.4%
Central Nervous System: 280.2m USD
9.3%
Auto-Injector: 209.5m USD
6.9%
Other Dosage Forms: 202.2m USD
6.7%
Transdermal: 180.9m USD
6%
Injectable: 165.4m USD
5.5%
Government: 160m USD
5.3%
Hormonal / Allergy: 130.4m USD
4.3%
Biosimilar: 125.4m USD
4.2%
Oral Liquid: 103.4m USD
3.4%
Institutional: 42.8m USD
1.4%
Other Therapeutic Classes: 28.6m USD
0.9%
Other: 26.3m USD
0.9%
International: 9m USD
0.3%
License Agreement: 6.5m USD
0.2%
Show More
Show Less
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett